COVID-19 Resource Center

Delivering Insights and Solutions for Success 

Helping You Make Educated Decisions to Keep Clinical Trials and Regulatory Submissions on Track

With COVID-19 continuing to impact people and countries around the globe, Veristat continues to monitor and adapt to provide sponsors with quality development and regulatory services while ensuring the safety of clients, patients, and communities. Whether you need to keep a current program on track or want to fast-track a COVID-19 diagnostic, treatment, or vaccine, we can help you navigate the ever-changing environment. Our expertise comes from planning or conducting more than 70 COVID-19 projects.

Veristat also offers proven virtual or decentralized trial models to accommodate travel/physical restrictions to medical facilities/sites. Our experts are available to assist you with clinical trial design, clinical trial conduct, and all the regulatory and safety support required to keep your clinical development programs on track.

Veristat study collaboration with HIPRA leads to EMA approval of BIMERVAX® COVID-19 vaccine, the first bivalent recombinant protein vaccine to be authorized in the EU and the first human health vaccine to be designed and developed in Spain.  


Let Us Help You Maintain Trial Integrity

We understand that the stakes are high no matter where you are in your development program. The stress, anxiety and uncertainty about ongoing, new, or COVID-19-related clinical programs is overwhelming. We have the agility and scientific-minded experts to help you navigate these uncertain times.